Axios @axios
Confirmed and probable Lyme disease cases in the U.S. have at least tripled since the late 1990s, but clinical trials for vaccines are underway. Pfizer and Valneva have developed a candidate that's in phase 2 human trials. https://t.co/rPG3NV2KkI — PolitiTweet.org